Alise Reicin
Direttore/Membro del Consiglio presso SANA BIOTECHNOLOGY, INC.
Patrimonio netto: 5 M $ in data 31/05/2024
Profilo
Alise S.
Reicin is currently the President, Chief Executive Officer & Director at Tectonic Operating Co., Inc. and Tectonic Therapeutic, Inc. She is also an Independent Director at Sana Biotechnology, Inc. and a Venture Advisor at Israel Biotech Fund.
Additionally, she serves as a Director at Sharsheret, Inc. In her former positions, Dr. Reicin was the Chief Executive Officer & Director at AVROBIO, Inc. and an Independent Director at Homology Medicines, Inc. She also held the position of President-Global Clinical Development at Celgene Corp.
from 2018 to 2019.
Prior to that, she was the VP-Oncology Program & Pipeline Leadership at Merck & Co., Inc. and the Head-Global Clinical Development at EMD Serono, Inc. from 2015 to 2018.
She was also a Member at Columbia University Vagelos College of Physicians & Surgeons.
Dr. Reicin completed her undergraduate degree at Barnard College in 1982 and obtained her doctorate from Harvard Medical School in 1987.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
7.81% | 20/06/2024 | 3 507 349 ( 7.81% ) | 5 M $ | 31/05/2024 |
-.--% | 14/06/2023 | 0 ( -.--% ) | - $ | 31/05/2024 |
SANA BIOTECHNOLOGY, INC.
-.--% | 06/06/2024 | 0 ( -.--% ) | - $ | 31/05/2024 |
Posizioni attive di Alise Reicin
| Società | Posizione | Inizio |
|---|---|---|
| SANA BIOTECHNOLOGY, INC. | Direttore/Membro del Consiglio | 01/12/2020 |
Tectonic Therapeutic, Inc.
 Tectonic Therapeutic, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Tectonic Therapeutic, Inc., Tectonic Operating Co., Inc. is a company that is transforming the discovery of antibodies and other biologic drugs targeting G-protein coupled receptors (GPCRs) to develop novel therapies for patients inadequately served by current treatments. The company is based in Watertown, MA. With its proprietary Geode™ platform, Tectonic aims to unlock the therapeutic utility of some of the most difficult receptors in the class. The company was founded by Andrew Kruse and Timothy A. Springer. Alise S. Reicin has been the CEO of the company since 2020. Tectonic Operating Co. was acquired by AVROBIO, Inc. on June 20, 2024 for $7.56 million. | Amministratore Delegato | 01/08/2020 |
Sharsheret, Inc.
 Sharsheret, Inc. Miscellaneous Commercial ServicesCommercial Services Sharsheret, Inc. is a leading Jewish cancer organization that provides free support and educational programs for breast cancer survivors. The non-profit company is based in Teaneck, NJ and the CEO of the company is Elana Silber. The company's program, Best Face Forward 2.0, offers services and subsidies for eligible individuals for non-medical services critical to a woman's quality of life. The company also offers support and resources for those who are BRCA+ or have a family history of BRCA. | Direttore/Membro del Consiglio | - |
Israel Biotech Fund
 Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | Consulente / Consigliere | - |
Precedenti posizioni note di Alise Reicin
| Società | Posizione | Fine |
|---|---|---|
| CELGENE | Corporate Officer/Principal | 01/12/2019 |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Direttore Tecnico/Scientifico/R&S | 01/10/2018 |
| TECTONIC THERAPEUTIC, INC. | Amministratore Delegato | - |
| MERCK & CO., INC. | Corporate Officer/Principal | - |
| Columbia University Vagelos College of Physicians & Surgeons | Corporate Officer/Principal | - |
Formazione di Alise Reicin
| Barnard College | Undergraduate Degree |
| Harvard Medical School | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| SANA BIOTECHNOLOGY, INC. | Health Technology |
| Aziende private | 7 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Homology Medicines, Inc.
 Homology Medicines, Inc. Pharmaceuticals: MajorHealth Technology Homology Medicines, Inc. is a clinical-stage genetic medicines company, which engages in the translation of proprietary gene editing and gene therapy technology into novel treatments for patients with rare genetic diseases. The company was founded in March 2015 and is headquartered in Bedford, MA. | Health Technology |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
Tectonic Therapeutic, Inc.
Tectonic Therapeutic, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Tectonic Therapeutic, Inc., Tectonic Operating Co., Inc. is a company that is transforming the discovery of antibodies and other biologic drugs targeting G-protein coupled receptors (GPCRs) to develop novel therapies for patients inadequately served by current treatments. The company is based in Watertown, MA. With its proprietary Geode™ platform, Tectonic aims to unlock the therapeutic utility of some of the most difficult receptors in the class. The company was founded by Andrew Kruse and Timothy A. Springer. Alise S. Reicin has been the CEO of the company since 2020. Tectonic Operating Co. was acquired by AVROBIO, Inc. on June 20, 2024 for $7.56 million. | Commercial Services |
Sharsheret, Inc.
Sharsheret, Inc. Miscellaneous Commercial ServicesCommercial Services Sharsheret, Inc. is a leading Jewish cancer organization that provides free support and educational programs for breast cancer survivors. The non-profit company is based in Teaneck, NJ and the CEO of the company is Elana Silber. The company's program, Best Face Forward 2.0, offers services and subsidies for eligible individuals for non-medical services critical to a woman's quality of life. The company also offers support and resources for those who are BRCA+ or have a family history of BRCA. | Commercial Services |
Israel Biotech Fund
Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | Finance |
Avrobio, Inc.
 Avrobio, Inc. BiotechnologyHealth Technology AVROBIO, Inc. engages in the development of lentiviral-based gene therapies. It focuses on developing potentially curative ex vivo lentiviral-based gene therapies to treat patients with rare diseases following a single dose treatment regimen. The firm's clinical-stage programs include Fabry, Gaucher Type 1, Hunter syndrome Gaucher Type 3, Pompe, and Cystinosis. The company was founded by Geoff Mackay, Kim Warren, Christopher Mason, and Jeffrey Medin in 2015 and is headquartered in Watertown, MA. | Health Technology |
- Borsa valori
- Insiders
- Alise Reicin
